Anika Therapeutics ANIK Increase Decrease In Lease Liabilities
Increase Decrease In Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Anika Therapeutics in its filing.
Tagged under the XBRL concept anik:IncreaseDecreaseInLeaseLiabilities.
The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Anika Therapeutics's increase decrease in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Anika Therapeutics's increase decrease in lease liabilities?
- Anika Therapeutics (ANIK) reported increase decrease in lease liabilities of -$468K in Q1 2026.
- How has Anika Therapeutics's increase decrease in lease liabilities changed year-over-year?
- Anika Therapeutics's increase decrease in lease liabilities increased by 17.8% year-over-year, from -$569K to -$468K.
- What is the long-term trend for Anika Therapeutics's increase decrease in lease liabilities?
- Over 4 years (2021 to 2025), Anika Therapeutics's increase decrease in lease liabilities has grown at a 5.3% compound annual growth rate (CAGR), from -$1.63M to -$2M.
- What does increase decrease in lease liabilities mean?
- This tracks the net change in the company's obligations arising from operating lease agreements, reflecting cash payments made to reduce lease liabilities. It provides insight into the company's fixed contractual commitments and its ongoing cash outflow requirements for leased facilities or equipment. Changes here are essential for assessing the company's long-term liquidity and operational footprint.